Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size, Status and Forecast 2024-2031

Report ID: 934545 | Published Date: Jan 2025 | No. of Page: 96 | Base Year: 2024 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Corticosteroids
        1.2.3 Phosphodiesterase Type 4 Inhibitors
        1.2.4 Bronchodilators
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Retail Pharmacies
        1.3.5 Other
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Perspective (2016-2027)
    2.2 Chronic Obstructive Pulmonary Disease (COPD) Treatment Growth Trends by Regions
        2.2.1 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Chronic Obstructive Pulmonary Disease (COPD) Treatment Historic Market Share by Regions (2016-2021)
        2.2.3 Chronic Obstructive Pulmonary Disease (COPD) Treatment Forecasted Market Size by Regions (2022-2027)
    2.3 Chronic Obstructive Pulmonary Disease (COPD) Treatment Industry Dynamic
        2.3.1 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Trends
        2.3.2 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Drivers
        2.3.3 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Challenges
        2.3.4 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Chronic Obstructive Pulmonary Disease (COPD) Treatment Players by Revenue
        3.1.1 Global Top Chronic Obstructive Pulmonary Disease (COPD) Treatment Players by Revenue (2016-2021)
        3.1.2 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue Market Share by Players (2016-2021)
    3.2 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue
    3.4 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Concentration Ratio
        3.4.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue in 2020
    3.5 Chronic Obstructive Pulmonary Disease (COPD) Treatment Key Players Head office and Area Served
    3.6 Key Players Chronic Obstructive Pulmonary Disease (COPD) Treatment Product Solution and Service
    3.7 Date of Enter into Chronic Obstructive Pulmonary Disease (COPD) Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Chronic Obstructive Pulmonary Disease (COPD) Treatment Breakdown Data by Type
    4.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Historic Market Size by Type (2016-2021)
    4.2 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Forecasted Market Size by Type (2022-2027)

5 Chronic Obstructive Pulmonary Disease (COPD) Treatment Breakdown Data by Application
    5.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Historic Market Size by Application (2016-2021)
    5.2 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size (2016-2027)
    6.2 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type
        6.2.1 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2016-2021)
        6.2.2 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2022-2027)
        6.2.3 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2016-2027)
    6.3 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application
        6.3.1 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2016-2021)
        6.3.2 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2022-2027)
        6.3.3 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2016-2027)
    6.4 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country
        6.4.1 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2016-2021)
        6.4.2 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size (2016-2027)
    7.2 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type
        7.2.1 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2016-2021)
        7.2.2 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2022-2027)
        7.2.3 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2016-2027)
    7.3 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application
        7.3.1 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2016-2021)
        7.3.2 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2022-2027)
        7.3.3 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2016-2027)
    7.4 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country
        7.4.1 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2016-2021)
        7.4.2 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size (2016-2027)
    8.2 Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type
        8.2.1 Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2016-2027)
    8.3 Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application
        8.3.1 Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2016-2027)
    8.4 Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Region
        8.4.1 Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size (2016-2027)
    9.2 Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type
        9.2.1 Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2016-2021)
        9.2.2 Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2022-2027)
        9.2.3 Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2016-2027)
    9.3 Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application
        9.3.1 Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2016-2021)
        9.3.2 Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2022-2027)
        9.3.3 Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2016-2027)
    9.4 Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country
        9.4.1 Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2016-2021)
        9.4.2 Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size (2016-2027)
    10.2 Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type
        10.2.1 Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2016-2027)
    10.3 Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application
        10.3.1 Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2016-2027)
    10.4 Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country
        10.4.1 Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 AstraZeneca
        11.1.1 AstraZeneca Company Details
        11.1.2 AstraZeneca Business Overview
        11.1.3 AstraZeneca Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction
        11.1.4 AstraZeneca Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2016-2021)
        11.1.5 AstraZeneca Recent Development
    11.2 Boehringer Ingelheim International GmbH
        11.2.1 Boehringer Ingelheim International GmbH Company Details
        11.2.2 Boehringer Ingelheim International GmbH Business Overview
        11.2.3 Boehringer Ingelheim International GmbH Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction
        11.2.4 Boehringer Ingelheim International GmbH Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2016-2021)
        11.2.5 Boehringer Ingelheim International GmbH Recent Development
    11.3 GlaxoSmithKline
        11.3.1 GlaxoSmithKline Company Details
        11.3.2 GlaxoSmithKline Business Overview
        11.3.3 GlaxoSmithKline Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction
        11.3.4 GlaxoSmithKline Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2016-2021)
        11.3.5 GlaxoSmithKline Recent Development
    11.4 Novartis AG
        11.4.1 Novartis AG Company Details
        11.4.2 Novartis AG Business Overview
        11.4.3 Novartis AG Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction
        11.4.4 Novartis AG Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2016-2021)
        11.4.5 Novartis AG Recent Development
    11.5 Teva Pharmaceutical Industries
        11.5.1 Teva Pharmaceutical Industries Company Details
        11.5.2 Teva Pharmaceutical Industries Business Overview
        11.5.3 Teva Pharmaceutical Industries Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction
        11.5.4 Teva Pharmaceutical Industries Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2016-2021)
        11.5.5 Teva Pharmaceutical Industries Recent Development
    11.6 Sunovion Pharmaceuticals
        11.6.1 Sunovion Pharmaceuticals Company Details
        11.6.2 Sunovion Pharmaceuticals Business Overview
        11.6.3 Sunovion Pharmaceuticals Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction
        11.6.4 Sunovion Pharmaceuticals Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2016-2021)
        11.6.5 Sunovion Pharmaceuticals Recent Development
    11.7 CHIESI Farmaceutici
        11.7.1 CHIESI Farmaceutici Company Details
        11.7.2 CHIESI Farmaceutici Business Overview
        11.7.3 CHIESI Farmaceutici Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction
        11.7.4 CHIESI Farmaceutici Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2016-2021)
        11.7.5 CHIESI Farmaceutici Recent Development
    11.8 Orion Corporation
        11.8.1 Orion Corporation Company Details
        11.8.2 Orion Corporation Business Overview
        11.8.3 Orion Corporation Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction
        11.8.4 Orion Corporation Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2016-2021)
        11.8.5 Orion Corporation Recent Development
    11.9 ​Mylan
        11.9.1 ​Mylan Company Details
        11.9.2 ​Mylan Business Overview
        11.9.3 ​Mylan Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction
        11.9.4 ​Mylan Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2016-2021)
        11.9.5 ​Mylan Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Corticosteroids
    Table 3. Key Players of Phosphodiesterase Type 4 Inhibitors
    Table 4. Key Players of Bronchodilators
    Table 5. Key Players of Others
    Table 6. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Regions (2016-2021) & (US$ Million)
    Table 9. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Regions (2016-2021)
    Table 10. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 11. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Regions (2022-2027)
    Table 12. Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Trends
    Table 13. Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Drivers
    Table 14. Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Challenges
    Table 15. Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Restraints
    Table 16. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue by Players (2016-2021) & (US$ Million)
    Table 17. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Players (2016-2021)
    Table 18. Global Top Chronic Obstructive Pulmonary Disease (COPD) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment as of 2020)
    Table 19. Ranking of Global Top Chronic Obstructive Pulmonary Disease (COPD) Treatment Companies by Revenue (US$ Million) in 2020
    Table 20. Global 5 Largest Players Market Share by Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue (CR5 and HHI) & (2016-2021)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Chronic Obstructive Pulmonary Disease (COPD) Treatment Product Solution and Service
    Table 23. Date of Enter into Chronic Obstructive Pulmonary Disease (COPD) Treatment Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 26. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue Market Share by Type (2016-2021)
    Table 27. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 28. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 29. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Share by Application (2016-2021) & (US$ Million)
    Table 30. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue Market Share by Application (2016-2021)
    Table 31. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 32. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 33. North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 34. North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 35. North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 36. North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 37. North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 38. North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 39. Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 40. Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 41. Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 42. Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 43. Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 44. Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 45. Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 48. Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Region (2016-2021) & (US$ Million) 
    Table 50. Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Region (2022-2027) & (US$ Million) 
    Table 51. Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 52. Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 53. Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 54. Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 55. Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 56. Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 57. Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 60. Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 62. Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 63. AstraZeneca Company Details
    Table 64. AstraZeneca Business Overview
    Table 65. AstraZeneca Chronic Obstructive Pulmonary Disease (COPD) Treatment Product
    Table 66. AstraZeneca Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2016-2021) & (US$ Million)
    Table 67. AstraZeneca Recent Development
    Table 68. Boehringer Ingelheim International GmbH Company Details
    Table 69. Boehringer Ingelheim International GmbH Business Overview
    Table 70. Boehringer Ingelheim International GmbH Chronic Obstructive Pulmonary Disease (COPD) Treatment Product
    Table 71. Boehringer Ingelheim International GmbH Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2016-2021) & (US$ Million)
    Table 72. Boehringer Ingelheim International GmbH Recent Development
    Table 73. GlaxoSmithKline Company Details
    Table 74. GlaxoSmithKline Business Overview
    Table 75. GlaxoSmithKline Chronic Obstructive Pulmonary Disease (COPD) Treatment Product
    Table 76. GlaxoSmithKline Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2016-2021) & (US$ Million)
    Table 77. GlaxoSmithKline Recent Development
    Table 78. Novartis AG Company Details
    Table 79. Novartis AG Business Overview
    Table 80. Novartis AG Chronic Obstructive Pulmonary Disease (COPD) Treatment Product
    Table 81. Novartis AG Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2016-2021) & (US$ Million)
    Table 82. Novartis AG Recent Development
    Table 83. Teva Pharmaceutical Industries Company Details
    Table 84. Teva Pharmaceutical Industries Business Overview
    Table 85. Teva Pharmaceutical Industries Chronic Obstructive Pulmonary Disease (COPD) Treatment Product
    Table 86. Teva Pharmaceutical Industries Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2016-2021) & (US$ Million)
    Table 87. Teva Pharmaceutical Industries Recent Development
    Table 88. Sunovion Pharmaceuticals Company Details
    Table 89. Sunovion Pharmaceuticals Business Overview
    Table 90. Sunovion Pharmaceuticals Chronic Obstructive Pulmonary Disease (COPD) Treatment Product
    Table 91. Sunovion Pharmaceuticals Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2016-2021) & (US$ Million)
    Table 92. Sunovion Pharmaceuticals Recent Development
    Table 93. CHIESI Farmaceutici Company Details
    Table 94. CHIESI Farmaceutici Business Overview
    Table 95. CHIESI Farmaceutici Chronic Obstructive Pulmonary Disease (COPD) Treatment Product
    Table 96. CHIESI Farmaceutici Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2016-2021) & (US$ Million)
    Table 97. CHIESI Farmaceutici Recent Development
    Table 98. Orion Corporation Company Details
    Table 99. Orion Corporation Business Overview
    Table 100. Orion Corporation Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2016-2021) & (US$ Million)
    Table 101. Orion Corporation Recent Development
    Table 102. ​Mylan Company Details
    Table 103. ​Mylan Business Overview
    Table 104. ​Mylan Chronic Obstructive Pulmonary Disease (COPD) Treatment Product
    Table 105. ​Mylan Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2016-2021) & (US$ Million)
    Table 106. ​Mylan Recent Development
    Table 107. Research Programs/Design for This Report
    Table 108. Key Data Information from Secondary Sources
    Table 109. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Type: 2020 VS 2027
    Figure 2. Corticosteroids Features
    Figure 3. Phosphodiesterase Type 4 Inhibitors Features
    Figure 4. Bronchodilators Features
    Figure 5. Others Features
    Figure 6. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Application: 2020 VS 2027
    Figure 7. Hospital Case Studies
    Figure 8. Clinic Case Studies
    Figure 9. Retail Pharmacies Case Studies
    Figure 10. Other Case Studies
    Figure 11. Chronic Obstructive Pulmonary Disease (COPD) Treatment Report Years Considered
    Figure 12. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 13. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 14. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Regions: 2020 VS 2027
    Figure 15. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Regions (2022-2027)
    Figure 16. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Players in 2020
    Figure 17. Global Top Chronic Obstructive Pulmonary Disease (COPD) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment as of 2020
    Figure 18. The Top 10 and 5 Players Market Share by Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue in 2020
    Figure 19. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue Market Share by Type (2016-2021)
    Figure 20. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue Market Share by Type (2022-2027)
    Figure 21. North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 22. North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Type (2016-2027)
    Figure 23. North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Application (2016-2027)
    Figure 24. North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Country (2016-2027)
    Figure 25. United States Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Canada Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Type (2016-2027)
    Figure 29. Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Application (2016-2027)
    Figure 30. Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Country (2016-2027)
    Figure 31. Germany Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. France Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. U.K. Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Italy Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Russia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Nordic Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Type (2016-2027)
    Figure 39. Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Application (2016-2027)
    Figure 40. Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Region (2016-2027)
    Figure 41. China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Japan Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. South Korea Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Southeast Asia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. India Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Australia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Type (2016-2027)
    Figure 49. Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Application (2016-2027)
    Figure 50. Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Country (2016-2027)
    Figure 51. Mexico Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Brazil Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Type (2016-2027)
    Figure 55. Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Application (2016-2027)
    Figure 56. Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Country (2016-2027)
    Figure 57. Turkey Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Saudi Arabia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. UAE Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. AstraZeneca Revenue Growth Rate in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2016-2021)
    Figure 61. Boehringer Ingelheim International GmbH Revenue Growth Rate in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2016-2021)
    Figure 62. GlaxoSmithKline Revenue Growth Rate in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2016-2021)
    Figure 63. Novartis AG Revenue Growth Rate in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2016-2021)
    Figure 64. Teva Pharmaceutical Industries Revenue Growth Rate in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2016-2021)
    Figure 65. Sunovion Pharmaceuticals Revenue Growth Rate in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2016-2021)
    Figure 66. CHIESI Farmaceutici Revenue Growth Rate in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2016-2021)
    Figure 67. Orion Corporation Revenue Growth Rate in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2016-2021)
    Figure 68. ​Mylan Revenue Growth Rate in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2016-2021)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AstraZeneca
Boehringer Ingelheim International GmbH
GlaxoSmithKline
Novartis AG
Teva Pharmaceutical Industries
Sunovion Pharmaceuticals
CHIESI Farmaceutici
Orion Corporation
​Mylan
Frequently Asked Questions
Chronic Obstructive Pulmonary Disease (COPD) Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Chronic Obstructive Pulmonary Disease (COPD) Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Chronic Obstructive Pulmonary Disease (COPD) Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports